Hepatitis Monthly

Published by: Kowsar

Incidence and Risk Factors for Liver Abscess After Thermal Ablation of Liver Neoplasm

Xiu-Feng Su 1 , 2 , Na Li 3 , Xu-Fang Chen 2 , Lei Zhang 4 and Ming Yan 1 , *
Authors Information
1 Department of Geriatric Gastroenterology, Qilu Hospital, Shandong University, Jinan, China
2 Department of Oncology, Yantai Affiliated Hospital, Binzhou Medical University, Yantai, China
3 Department of Rheumatology, Yantai Affiliated Hospital, Binzhou Medical University, Yantai, China
4 Department of Infectious Diseases, Yantai Affiliated Hospital, Binzhou Medical University, Yantai, China
Article information
  • Hepatitis Monthly: July 01, 2016, 16 (7); e34588
  • Published Online: May 23, 2016
  • Article Type: Research Article
  • Received: November 11, 2015
  • Revised: April 16, 2016
  • Accepted: April 21, 2016
  • DOI: 10.5812/hepatmon.34588

To Cite: Su X, Li N, Chen X, Zhang L, Yan M. et al. Incidence and Risk Factors for Liver Abscess After Thermal Ablation of Liver Neoplasm, Hepat Mon. 2016 ;16(7):e34588. doi: 10.5812/hepatmon.34588.

Abstract
Copyright © 2016, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Footnote
References
  • 1. Shiina S, Tateishi R, Arano T, Uchino K, Enooku K, Nakagawa H, et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol. 2012; 107(4): 569-77[DOI][PubMed]
  • 2. Xu G, Qi FZ, Zhang JH, Cheng GF, Cai Y, Miao Y. Meta-analysis of surgical resection and radiofrequency ablation for early hepatocellular carcinoma. World J Surg Oncol. 2012; 10: 163[DOI][PubMed]
  • 3. Fu C, Liu N, Deng Q, Li X, Ma K, Bie P. Radiofrequency ablation vs. surgical resection on the treatment of patients with small hepatocellular carcinoma: a system review and meta-analysis of five randomized controlled trials. Hepatogastroenterology. 2014; 61(134): 1722-9[PubMed]
  • 4. Feng Q, Chi Y, Liu Y, Zhang L, Liu Q. Efficacy and safety of percutaneous radiofrequency ablation versus surgical resection for small hepatocellular carcinoma: a meta-analysis of 23 studies. J Cancer Res Clin Oncol. 2015; 141(1): 1-9[DOI][PubMed]
  • 5. Groeschl RT, Pilgrim CH, Hanna EM, Simo KA, Swan RZ, Sindram D, et al. Microwave ablation for hepatic malignancies: a multiinstitutional analysis. Ann Surg. 2014; 259(6): 1195-200[DOI][PubMed]
  • 6. Clinical Practice Guidelines for Hepatocellular Carcinoma - The Japan Society of Hepatology 2009 update. Hepatol Res. 2010; 40 Suppl 1: 2-144[DOI][PubMed]
  • 7. Takaki H, Yamakado K, Nakatsuka A, Yamada T, Shiraki K, Takei Y, et al. Frequency of and risk factors for complications after liver radiofrequency ablation under CT fluoroscopic guidance in 1500 sessions: single-center experience. AJR Am J Roentgenol. 2013; 200(3): 658-64[DOI][PubMed]
  • 8. Bertot LC, Sato M, Tateishi R, Yoshida H, Koike K. Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review. Eur Radiol. 2011; 21(12): 2584-96[DOI][PubMed]
  • 9. Ding J, Jing X, Liu J, Wang Y, Wang F, Wang Y, et al. Complications of thermal ablation of hepatic tumours: comparison of radiofrequency and microwave ablative techniques. Clin Radiol. 2013; 68(6): 608-15[DOI][PubMed]
  • 10. Liang P, Wang Y, Yu X, Dong B. Malignant liver tumors: treatment with percutaneous microwave ablation--complications among cohort of 1136 patients. Radiology. 2009; 251(3): 933-40[DOI][PubMed]
  • 11. Livraghi T, Meloni F, Solbiati L, Zanus G, Collaborative Italian Group using AS. Complications of microwave ablation for liver tumors: results of a multicenter study. Cardiovasc Intervent Radiol. 2012; 35(4): 868-74[DOI][PubMed]
  • 12. Ye SL QS, Wu MC. Expert consensus of the Standardized diagnosis and treatment for Hepatocellular carcinoma. J Clin Hepatol. 2009; 12(5)
  • 13. Zhang X, Zhou L, Chen B, Hu S, Wachtel MS, Frezza EE. Microwave ablation with cooled-tip electrode for liver cancer: an analysis of 160 cases. Minim Invasive Ther Allied Technol. 2008; 17(5): 303-7[DOI][PubMed]
  • 14. Tanaka S, Shimada M, Shirabe K, Taketomi A, Maehara S, Tsujita E, et al. Surgical radiofrequency ablation for treatment of hepatocellular carcinoma: an endoscopic or open approach. Hepatogastroenterology. 2009; 56(93): 1169-73[PubMed]
  • 15. Salama IA, Korayem E, ElAbd O, El-Refaie A. Laparoscopic ultrasound with radiofrequency ablation of hepatic tumors in cirrhotic patients. J Laparoendosc Adv Surg Tech A. 2010; 20(1): 39-46[DOI][PubMed]
  • 16. Zhang XG, Zhang ZL, Hu SY, Wang YL. Ultrasound-guided ablative therapy for hepatic malignancies : a comparison of the therapeutic effects of microwave and radiofrequency ablation. Acta Chir Belg. 2014; 114(1): 40-5[PubMed]
  • 17. Martin RC, Scoggins CR, McMasters KM. Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience. Ann Surg Oncol. 2010; 17(1): 171-8[DOI][PubMed]
  • 18. Rhim H, Lim HK, Kim YS, Choi D. Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma in the hepatic dome: initial experience. AJR Am J Roentgenol. 2008; 190(1): 91-8[DOI][PubMed]
  • 19. Song I, Rhim H, Lim HK, Kim YS, Choi D. Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients. Eur Radiol. 2009; 19(11): 2630-40[DOI][PubMed]
  • 20. Kurokohchi K, Watanabe S, Yoneyama H, Deguchi A, Masaki T, Himoto T, et al. A combination therapy of ethanol injection and radiofrequency ablation under general anesthesia for the treatment of hepatocellular carcinoma. World J Gastroenterol. 2008; 14(13): 2037-43[PubMed]
  • 21. Shibata T, Yamamoto Y, Yamamoto N, Maetani Y, Shibata T, Ikai I, et al. Cholangitis and liver abscess after percutaneous ablation therapy for liver tumors: incidence and risk factors. J Vasc Interv Radiol. 2003; 14(12): 1535-42[PubMed]
  • 22. Choi D, Lim HK, Kim MJ, Kim SJ, Kim SH, Lee WJ, et al. Liver abscess after percutaneous radiofrequency ablation for hepatocellular carcinomas: frequency and risk factors. AJR Am J Roentgenol. 2005; 184(6): 1860-7[DOI][PubMed]
  • 23. Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR, Charboneau JW, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. Radiology. 2014; 273(1): 241-60[DOI][PubMed]
  • 24. Wang XH, Yu J, Liang P, Yu XL, Cheng ZG, Han ZY, et al. [Percutaneous cooled-tip microwave ablation under ultrasound guidance for primary liver cancer: analysis of major complications in 693 patients]. Zhonghua Zhong Liu Za Zhi. 2012; 34(12): 945-9[DOI][PubMed]
  • 25. Oshima S, Tani N, Takaishi K, Hirano M, Makari Y, Hoshi M, et al. [Clinical evaluation of the risk factors for liver abscess after TACE or RFA]. Gan To Kagaku Ryoho. 2014; 41(12): 2113-5[PubMed]
  • 26. Rhim H, Yoon KH, Lee JM, Cho Y, Cho JS, Kim SH, et al. Major complications after radio-frequency thermal ablation of hepatic tumors: spectrum of imaging findings. Radiographics. 2003; 23(1): 123-34[DOI][PubMed]
  • 27. Hope WW, Vrochides DV, Newcomb WL, Mayo-Smith WW, Iannitti DA. Optimal treatment of hepatic abscess. Am Surg. 2008; 74(2): 178-82[PubMed]
  • 28. de Baere T, Risse O, Kuoch V, Dromain C, Sengel C, Smayra T, et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol. 2003; 181(3): 695-700[DOI][PubMed]
  • 29. Giorgio A, Ferraioli G. Liver abscess formation after radiofrequency ablation in patients with hepatocellular carcinoma. AJR Am J Roentgenol. 2006; 186(2): 582[DOI][PubMed]
  • 30. Kim JH, Won HJ, Shin YM, Kim PN, Lee SG, Hwang S. Radiofrequency ablation for recurrent intrahepatic cholangiocarcinoma after curative resection. Eur J Radiol. 2011; 80(3)-5[DOI][PubMed]
  • 31. Kondo Y, Shiina S, Tateishi R, Arano T, Uchino K, Enooku K, et al. Intrahepatic bile duct dilatation after percutaneous radiofrequency ablation for hepatocellular carcinoma: impact on patient's prognosis. Liver Int. 2011; 31(2): 197-205[DOI][PubMed]
  • 32. Chang IS, Rhim H, Kim SH, Kim YS, Choi D, Park Y, et al. Biloma formation after radiofrequency ablation of hepatocellular carcinoma: incidence, imaging features, and clinical significance. AJR Am J Roentgenol. 2010; 195(5): 1131-6[DOI][PubMed]
  • 33. Minami Y, Kudo M. Radiofrequency ablation of hepatocellular carcinoma: a literature review. Int J Hepatol. 2011; 2011: 104685[DOI][PubMed]
  • 34. Keynan Y, Rubinstein E. Diabetes mellitus and pyogenic liver abscess: risk and prognosis. Clin Infect Dis. 2007; 45(6): 801[DOI][PubMed]
  • 35. Azab M, Zaki S, El-Shetey AG, Abdel-Moty MF, Alnoomani NM, Gomaa AA, et al. Radiofrequency ablation combined with percutaneous ethanol injection in patients with hepatocellular carcinoma. Arab J Gastroenterol. 2011; 12(3): 113-8[DOI][PubMed]
  • 36. Hoffmann R, Rempp H, Schmidt D, Pereira PL, Claussen CD, Clasen S. Prolonged antibiotic prophylaxis in patients with bilioenteric anastomosis undergoing percutaneous radiofrequency ablation. J Vasc Interv Radiol. 2012; 23(4): 545-51[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments